Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

<p>Supplementary Tables S2-13</p>

保存先:

書誌詳細
第一著者:	Francisco Hermida-Prado (14958909) (author)
その他の著者:	Yingtian Xie (14958900) (author), Shira Sherman (17078923) (author), Zsuzsanna Nagy (14958888) (author), Douglas Russo (15051419) (author), Tara Akhshi (17078926) (author), Zhengtao Chu (17078929) (author), Avery Feit (14958894) (author), Marco Campisi (14960085) (author), Minyue Chen (15132641) (author), Agostina Nardone (14958879) (author), Cristina Guarducci (14958906) (author), Klothilda Lim (14958912) (author), Alba Font-Tello (14958903) (author), Irene Lee (17078932) (author), Juana García-Pedrero (17078935) (author), Israel Cañadas (15116782) (author), Judith Agudo (17078938) (author), Ying Huang (17078941) (author), Tal Sella (15907645) (author), Qingchun Jin (17078944) (author), Nabihah Tayob (15029789) (author), Elizabeth A. Mittendorf (15454561) (author), Sara M. Tolaney (15051440) (author), Xintao Qiu (14958882) (author), Henry Long (14958854) (author), William F. Symmans (15056362) (author), Jia-Ren Lin (15033015) (author), Sandro Santagata (14941840) (author), Isabelle Bedrosian (15043389) (author), Denise A. Yardley (17078947) (author), Ingrid A. Mayer (16617143) (author), Edward T. Richardson (17078950) (author), Giacomo Oliveira (17078953) (author), Catherine J. Wu (14944480) (author), Eugene F. Schuster (17078956) (author), Mitch Dowsett (15046881) (author), Alana L. Welm (11627892) (author), David Barbie (17078959) (author), Otto Metzger (17078962) (author), Rinath Jeselsohn (14948026) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Immuno-oncology Breast Cancer Immunotherapy Tumor Microenvironment Immune cells and the microenvironment
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Table S13 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma.
著者:: Fengyi Mao (15073242)
出版事項: (2025)

Additional file 13 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
著者:: Xu Han (141301)
出版事項: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S11 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S14 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S15 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S16 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S17 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S2 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S3 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S4 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S6 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S7 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S8 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Table S1 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S2 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S3 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S4 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S5 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S6 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Table S7 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2<sup>+</sup> Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
著者:: Fanfan Fan (16799646)
出版事項: (2025)

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
著者:: Andrew A. Davis (15030032)
出版事項: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
著者:: Andrew O. Yam (15293045)
出版事項: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
著者:: Andrew O. Yam (15293045)
出版事項: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
著者:: Andrew O. Yam (15293045)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_t09lhn37rmesia3utd5b2e7e5b